Results: 11
Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2890, doi. 10.1111/1759-7714.15097
- By:
- Publication type:
- Article
The role of microbiota in esophageal squamous cell carcinoma: A review of the literature.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2821, doi. 10.1111/1759-7714.15096
- By:
- Publication type:
- Article
Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M‐positive: Case report and literature review.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2886, doi. 10.1111/1759-7714.15081
- By:
- Publication type:
- Article
Role of prognostic nutritional index in postoperative radiotherapy for non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2859, doi. 10.1111/1759-7714.15074
- By:
- Publication type:
- Article
An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2813, doi. 10.1111/1759-7714.15071
- By:
- Publication type:
- Article
Real‐world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non‐small cell lung cancer in the EU5.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2846, doi. 10.1111/1759-7714.15069
- By:
- Publication type:
- Article
Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2839, doi. 10.1111/1759-7714.15068
- By:
- Publication type:
- Article
Preliminary investigation of elevated collagen and blood‐clotting markers as potential noninvasive biomarkers for small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2830, doi. 10.1111/1759-7714.15066
- By:
- Publication type:
- Article
Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB–III non‐small cell lung cancer patients using radiomic features.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2869, doi. 10.1111/1759-7714.15052
- By:
- Publication type:
- Article
Investigation of the efficacy and feasibility of combined therapy of PD‐L1‐enhanced exogenous peripatetic adoptive natural killer (NK) cells in combination with antiangiogenic targeted therapy in the treatment of extensive‐stage small cell lung cancer
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2877, doi. 10.1111/1759-7714.15040
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 28, p. 2811, doi. 10.1111/1759-7714.14514
- Publication type:
- Article